why would someone not lose weight on semaglutide Am I Losing Semaglutide: Medical Causes Explained Semaglutide Non-Response: Why Some Don't

Semaglutide is a medication that belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists

According to the WHO, obesity has reached epidemic proportions, estimating that more than one billion adults worldwide will be obese by 2030 [6]

At USD 1,349 per month list price for Wegovy and USD 1,059 for Zepbound, monthly GLP-1 obesity drug costs create absolute financial barriers for the 62% of obesity patients enrolled in Medicaid, Medicare, or underinsured commercial plans without anti-obesity medication benefits

This emotional strain is significant, turning a hopeful treatment into a source of stress for many individuals

The Emotional Rollercoaster: Bipolar Disorder and GLP-1s